|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1301 CONNECTICUT AVENUE, NW, #700 |
Address2 |
|
| City | WASHINGTON |
State | DC |
Zip Code | 20036 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 738-12
|
||||||||
|
6. House ID# 303180000
|
||||||||
| TYPE OF REPORT | 8. Year | 2026 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Kelly Baden |
Date | 10/20/2026 3:44:02 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
FY 27 Appropriations- Signed on to letter to House and Senate appropriators opposing anti-abortion riders in Defense and MilConVA Approps Bills
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Samira |
Damavandi |
|
Senior Federal Policy Associate |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FAM
16. Specific lobbying issues
-Standing call with Senate staff on reproductive health and rights issues
-H.R. 4611- The EACH Act- met with House offices to cosponsor the bill
-Meeting with Rep. Pettersen's office to discuss potential letter to EPA regarding EPA action on mifepristone
- Meeting with Senator Merkley's office on potential resolution or oversight letter regarding EPA action on mifepristone
- Briefing to Hill staff with asks including opposing H.R.7983 (Clean Water for All Life Act) and appropriations riders related to mifepristone environmental claims
- Letter to Senate HELP Committee opposing FDA commissioner nominee Heidi Overton
- Worked with Senator Murray's office on oversight letter regarding EPA action on mifepristone
- HR 10597, S 5539- Affordability is Access Act, emailed House and Senate offices to get cosponsors on bill
- S 5108, HR 9941- Right to IVF Act, endorsed bill
- HR 10600, S 5565- Abortion is Healthcare Everywhere Act- Social media content development and engagement in support of bill re-introduction, Met with Rep. Schakowsky and Sen. Booker staff; emails to House and Senate for cosponsorship.
- HR 10597, S 5539- Affordability Is Access Act- Social media content development and engagement in support of bill re-introduction, emails to House for cosponsorship
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Anna |
Bernstein |
|
Principal Federal Policy Advisor |
|
Samira |
Damavandi |
|
Senior Federal Policy Associate |
|
Noli |
Vega |
|
Senior Digital Communications Manager |
|
Amy |
Friedrich-Karnik |
|
Director of Federal Policy |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FOR
16. Specific lobbying issues
-HR 10600, S 5565-Abortion is Healthcare Everywhere Act- Met with Rep. Schakowsky and Sen. Booker staff on bill reintroduction, reviewed text, emails to House and Senate for cosponsors, social media content development and engagement in support of bill re-introduction.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Samira |
Damavandi |
|
Senior Federal Policy Associate |
|
Amy |
Friedrich-Karnik |
|
Director of Federal Policy |
|
Noli |
Vega |
|
Senior Digital Communications Manager |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
- HR 4104- Health Equity and Access under the Law for Immigrant Families Act of 2025- emails to House for cosponsorship
- HR 10597, S 5539- Affordability is Access Act, emails to House and Senate for cosponsorship, social media content development and engagement in support of bill re-introduction.
-Letter to Senate HELP Committee opposing FDA commissioner nominee Heidi Overton
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Anna |
Bernstein |
|
Principal Federal Policy Advisor |
|
Amy |
Friedrich-Karnik |
|
Director of Federal Policy |
|
Noli |
Vega |
|
Senior Digital Communications Manager |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |